1295 Stock Overview
Synbio Tech Inc. engages in the research and manufacture of probiotics.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Synbio Tech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$71.00 |
| 52 Week High | NT$92.00 |
| 52 Week Low | NT$60.00 |
| Beta | 0 |
| 1 Month Change | -1.39% |
| 3 Month Change | -10.69% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -8.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1295 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -4.1% | 3.2% | 1.1% |
| 1Y | n/a | -24.1% | 28.2% |
Return vs Industry: Insufficient data to determine how 1295 performed against the TW Biotechs industry.
Return vs Market: Insufficient data to determine how 1295 performed against the TW Market.
Price Volatility
| 1295 volatility | |
|---|---|
| 1295 Average Weekly Movement | 5.0% |
| Biotechs Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in TW Market | 8.8% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 1295 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 1295's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | n/a | www.synbiotech.com |
Synbio Tech Inc. engages in the research and manufacture of probiotics. The company provides SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and promote human health; SynForU-ImmuUp for immune system; SynForU-GastroKeep, a stomach care probiotic; SynForU-HepaAid, a liver care probiotic; SynForU-HerCare, which inhibit the growth of fungal and bacterial pathogens, and maintain the vaginal microbiome in proper balance; SynForU-Remain, a kidney care solution; and multi strain probiotics. Its single probiotics strain includes bacillus coagulans, bifidobacterium animalis subsp.
Synbio Tech Inc. Fundamentals Summary
| 1295 fundamental statistics | |
|---|---|
| Market cap | NT$2.18b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 1295 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1295 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 1295 perform over the long term?
See historical performance and comparison